ACTRN12619001647123终止未知
Multi-centre prospective randomised placebo-controlled study to evaluate the role of Intravenous Fentanyl during DC cardioversion for the treatment of acute onset Atrial fibrillation. (DAFF Study – Direct Current Cardioversion, Atrial Fibrillation and Fentanyl use)
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 128
研究概览
简要总结
o results available yet for plain english summary
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Adult patients (Age >18 year)
- •Able to provide informed consent to enrol in study
- •Atrial fibrillation deemed clinically appropriate for DC cardioversion using procedural sedation and analgesia.
- •No allergy to Propofol or Fentanyl
排除标准
- •Refusal of consent
- •Allergy to Fentanyl or Propofol
- •Dose of intravenous fentanyl in the preceding 2 hours prior to procedure
- •Atrial fibrillation duration unknown
- •Intercurrent Monoamine Oxidase inhibitor use
- •Severe Impariment of Pulmonary reserve
- •Hepatic failure
- •Renal failure
研究者
相似试验
已完成
4 期
A study to evaluate the use of Oscillococcinum�® in the treatment of Influenza-like-illness symptoms.CTRI/2021/02/031250Boiron Laboratoires755
已完成
不适用
Evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage.Topic: Injuries and Emergencies, HaematologySubtopic: Injuries and Emergencies (All Subtopics), Haematology (All Subtopics)Disease: Injuries and Emergencies, Non-malignant HaematologyInjury, Occupational Diseases, PoisoningISRCTN67540073HS Blood and Transplant (NHSBT)48
已完成
2 期
Repurposing anti-TNF for treating Dupuytren’s diseaseDupuytren's disease of the handSkin and Connective Tissue DiseasesDupuytren's diseaseISRCTN27786905niversity of Oxford181
已完成
不适用
Managing Avascular Necrosis Treatments: an Investigational Study (MANTIS)Avascular necrosis of the hipMusculoskeletal DiseasesOsteonecrosisISRCTN14015902niversity of Oxford21
已完成
不适用
A clinical study to evaluate the Efficacy and Safety of the Herbal medicine - SanAshwa in the management of Stress and Anxiety in Healthy Adult volunteers.CTRI/2016/11/007478Sandhu Products Inc70